References
- CasellasFArenasJIBaudetJSImpairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter studyInflamm Bowel Dis200511548849615867589
- VergaraMMontserratACasellasFA new validation of the Spanish Work Productivity and Activity Impairment Questionnaire-Crohn’s disease versionValue Health201114685986121914506
- SorensenVZOlsenBGBinderVLife prospects and quality of life in patients with Crohn’s diseaseGut19872843823853583066
- DrossmanDAPatrickDLMitchellCMZagamiEAAppelbaumMIHealth-related quality of life in inflammatory bowel disease. Functional status and patient worries and concernsDig Dis Sci1989349137913862766905
- IrvineEJQuality of life issues in patients with inflammatory bowel diseaseAm J Gastroenterol1997921218s24s9395348
- GoodhandJRWahedMMawdsleyJEFarmerADAzizQRamptonDSMood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factorsInflamm Bowel Dis201218122301230922359369
- van der HaveMBrakenhoffLKvan ErpSJBack/joint pain, illness perceptions and coping are important predictors of quality of life and work productivity in patients with inflammatory bowel disease: a 12-month longitudinal studyJ Crohns Colitis20159327628325547976
- KnowlesSRCookSITribbickDRelationship between health status, illness perceptions, coping strategies and psychological morbidity: a preliminary study with IBD stoma patientsJ Crohns Colitis2013710e471e47823541738
- LeventhalHMeyerDNerenzDThe common sense model of illness dangerPetrieKWeinmanJPerceptions of Health and IllnessAmsterdamOPA19801946
- HaggerMSOrbellSA meta-analytic review of the common-sense model of illness representationsPsychol Health200318141184
- ZhangMHongLZhangTIllness perceptions and stress: mediators between disease severity and psychological well-being and quality of life among patients with Crohn’s diseasePatient Prefer Adherence2016102387239627920505
- KnowlesSRWilsonJLConnellWRKammMAPreliminary examination of the relations between disease activity, illness perceptions, coping strategies, and psychological morbidity in Crohn’s disease guided by the common sense model of illnessInflamm Bowel Dis201117122551255721425208
- KieblesJLDoerflerBKeeferLPreliminary evidence supporting a framework of psychological adjustment to inflammatory bowel diseaseInflamm Bowel Dis201016101685169520155849
- SiegelCAWhat options do we have for induction therapy for Crohn’s disease?Dig Dis201028354354720926884
- TravisSPStangeEFLemannMEuropean evidence based consensus on the diagnosis and management of Crohn’s disease: current managementGut200655Suppl 1i16i3516481629
- HarveyRFBradshawJMA simple index of Crohn’s-disease activityLancet1980181675146102236
- BestWRBecktelJMSingletonJWKernFJrDevelopment of a Crohn’s disease activity index. National Cooperative Crohn’s Disease StudyGastroenterology19767034394441248701
- BroadbentEPetrieKJMainJWeinmanJThe brief illness perception questionnaireJ Psychosom Res200660663163716731240
- CarverCSYou want to measure coping but your protocol’s too long: consider the brief COPEInt J Behav Med1997419210016250744
- McCombieAMMulderRTGearryRBCoping strategies and psychological outcomes of patients with inflammatory bowel disease in the first 6 months after diagnosisInflamm Bowel Dis201521102272228026099065
- ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand19836763613706880820
- GuyattGMitchellAIrvineEJA new measure of health status for clinical trials in inflammatory bowel diseaseGastroenterology19899638048102644154
- RutgeertsPFeaganBGLichtensteinGRComparison of scheduled and episodic treatment strategies of infliximab in Crohn’s diseaseGastroenterology2004126240241314762776
- LonnkvistMHBefritsRLundbergJOInfliximab in clinical routine: experience with Crohn’s disease and biomarkers of inflammation over 5 yearsEur J Gastroenterol Hepatol200921101168117619757522
- FanRZhongJWangZTEvaluation of “top-down” treatment of early Crohn’s disease by double balloon enteroscopyWorld J Gastroenterol20142039144791448725339835
- ColombelJFReinischWMantzarisGJRandomised clinical trial: deep remission in biologic and immunomodulator naive patients with Crohn’s disease – a SONIC post hoc analysisAliment Pharmacol Ther201541873474625728587
- ChoiCHSongIDKimYHEfficacy and safety of infliximab therapy and predictors of response in Korean patients with Crohn’s disease: a nationwide, multicenter studyYonsei Med J20165761376138527593865
- TribbickDSalzbergMConnellWDifferences across illness perceptions in inflammatory bowel disease and their relationships to psychological distress and quality of lifeGastroenterol Nurs201740429129928746114
- DorrianADempsterMAdairPAdjustment to inflammatory bowel disease: the relative influence of illness perceptions and copingInflamm Bowel Dis2009151475518626980
- RochelleTLFidlerHThe importance of illness perceptions, quality of life and psychological status in patients with ulcerative colitis and Crohn’s diseaseJ Health Psychol201318797298323027780
- van der HaveMMinderhoudIMKapteinAASubstantial impact of illness perceptions on quality of life in patients with Crohn’s diseaseJ Crohns Colitis201378e292e30123218732
- KnowlesSRGassCMacraeFIllness perceptions in IBD influence psychological status, sexual health and satisfaction, body image and relational functioning: a preliminary exploration using Structural Equation ModelingJ Crohns Colitis201379e344e35023453888
- CalvetXGallardoOCoronasRRemission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohn’s diseaseInflamm Bowel Dis200612869269616917223
- CasellasFLópez-VivancosJBadiaXVilasecaJMalageladaJRInfluence of inflammatory bowel disease on different dimensions of quality of lifeEur J Gastroenterol Hepatol200113556757211396538
- CasellasFLópez-VivancosJBadiaXVilasecaJMalageladaJRImpact of surgery for Crohn’s disease on health-related quality of lifeAm J Gastroenterol200095117718210638579
- LichtensteinGRBalaMHanCDeWoodyKSchaibleTInfliximab improves quality of life in patients with Crohn’s diseaseInflamm Bowel Dis20028423724312131606
- CadahiaVGarcia-CarboneroAVivasSInfliximab improves quality of life in the short-term in patients with fistulizing Crohn’s disease in clinical practiceRev Esp Enferm Dig200496369–374747814971999
- DelaneyCPKiranRPSenagoreAJQuality of life improves within 30 days of surgery for Crohn’s diseaseJ Am Coll Surg2003196571472112742203
- van BalkomBPSchoonEJStockbruggerRWEffects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn’s diseaseAliment Pharmacol Ther20021661101110712030951
- ThomsenOOCortotAJewellDBudesonide and mesalazine in active Crohn’s disease: a comparison of the effects on quality of lifeAm J Gastroenterol200297364965311922560
- IrvineEJGreenbergGRFeaganBGQuality of life rapidly improves with budesonide therapy for active Crohn’s disease. Canadian Inflammatory Bowel Disease Study GroupInflam Bowel Dis200063181187
- OtleyARGriffithsAMHaleSHealth-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel diseaseInflamm Bowel Dis200612868469116917222
- Herrera-deGuiseCCasellasFRoblesVNavarroEBorruelNPredictive value of early restoration of quality of life in Crohn’s disease patients receiving antitumor necrosis factor agentsJ Gastroenterol Hepatol201530228629125302652
- MittermaierCDejacoCWaldhoerTImpact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up studyPsychosom Med2004661798414747641
- CamaraRJJuilleratPPittetVQuality of life: a potentially useful measure to indicate subclinical flares in Crohn diseaseIntern Med J2012427e145e15121395959
- RutgeertsPDiamondRHBalaMScheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn’s diseaseGastrointest Endosc2006633433442 quiz 6416500392
- FroslieKFJahnsenJMoumBAVatnMHMucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohortGastroenterology2007133241242217681162
- SchnitzlerFFidderHFerranteMMucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn’s diseaseInflamm Bowel Dis20091591295130119340881
- HanauerSBFeaganBGLichtensteinGRMaintenance inflix-imab for Crohn’s disease: the ACCENT I randomised trialLancet200235993171541154912047962
- CasellasFRodrigoLNiñoPPantigaCRiestraSMalageladaJRSustained improvement of health-related quality of life in Crohn’s disease patients treated with infliximab and azathioprine for 4 yearsInflamm Bowel Dis200713111395140017567874